Analyst Ratings for BioCryst Pharma (BCRX) [Neutrals]
BCRX Rating Summary
BCRX Price Target Summary
- Highest: $14.00 (JMP Securities)
- Lowest: $6.00 (Barclays)
- Average: $10.17
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.17 (+141.5%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 85%
Avg. $ Target:
$10.17 (+141.5%)
* Over Last 12-Mos
Rating Score: 8.1 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/5/2022 | Oppenheimer | Justin Kim | Downgrade | Perform (Outperform) |
N/A (N/A) |
11.15 (4.21) |
-62.24% | Details |
| 4/18/2022 | Barclays » Updated 11/3/2023 |
Gena Wang | Downgrade | Equalweight (Overweight) |
6.00 (8.00) |
11.39 (4.21) |
-63.04% | Details |
 |
||||||||
|
||||||||
